Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...

In the quest for longevity and reversing biological age, Bryan Johnson, a tech entrepreneur known for his extensive efforts ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating ...

A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...

Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...